Validation by ELISA showed APOA1 expression which is consistent with the DIGE findings both in normal controls versus early CRC and normal controls versus late CRC (Fig. 2a); whereas GAL-7 expression status was only comparable in normal controls vs. early CRC (Fig. 2b). The gene discussed is APOA1; the disease is colorectal carcinoma.